METTL14, an essential element of the m6A writer complex, has been found to be highly expressed in both normal hematopoietic stem cells (HSCs) and acute myeloid leukemia (AML) cells; however, its expression decreases when these cells begin to differentiate. Here, METTL14 is linked to acute myeloid leukemia.